- 英文名称
- (+)-Syringaresinol
- 分子式
- C22H26O8
- 分子量
- 418.44
- 中文别名
- 4,4'-((1S,3aR,4S,6aR)-四氢-1H,3H-呋喃并[3,4-c]呋喃-1,4-二基)双(2,6-二甲氧基苯酚); (+)-丁香脂素; 4,4'-((1S,3aR,4S,6aR)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis(2,6-dimethoxyphenol); (+)-(7S,7'S,8R,8'R)-4,4'-dihydroxy-3,3',5,5'-tetramethoxy-7,9':7',9-diepoxylignane; syringaresinol; (-) Syringaresinol; (+)-lirioresinol B; (+/-)-syringaresinol; 4,4'-(tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl)bis[2,6-dimethoxyphenyl]; 4-[(3S,3aR,6S,6aR)-6-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2,6-dimethoxyphenol; DL-Syringaresinol; syringarenol; (1S,3aβ,6aβ)-Tetrahydro-1β,4β-bis(3,5-dimethoxy-4-hydroxyphenyl)-1H,3H-furo[3,4-c]furan; 4,4'-[(1S,3aβ,6aβ)-Tetrahydro-1H,3H-furo[3,4-c]furan-1β,4β-diyl]bis(2,6-dimethoxyphenol); Lirioresinol B
- 用途
- 概述：(+)-丁香树脂酚是一种木脂素，是NFAT转录因子抑制剂，IC50值为329.4 μM。也可用于淋巴细胞白血病的研究。来源：生命科学；中草药成分。
